Release Date: 02/02/17 17:05 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 116.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%